Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
DpULTxVPPQdQrV6g